1. Home
  2. NMTC vs GSIW Comparison

NMTC vs GSIW Comparison

Compare NMTC & GSIW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NMTC
  • GSIW
  • Stock Information
  • Founded
  • NMTC 2009
  • GSIW 2016
  • Country
  • NMTC United States
  • GSIW Hong Kong
  • Employees
  • NMTC N/A
  • GSIW N/A
  • Industry
  • NMTC Medical/Dental Instruments
  • GSIW
  • Sector
  • NMTC Health Care
  • GSIW
  • Exchange
  • NMTC Nasdaq
  • GSIW Nasdaq
  • Market Cap
  • NMTC 33.8M
  • GSIW 27.2M
  • IPO Year
  • NMTC N/A
  • GSIW 2023
  • Fundamental
  • Price
  • NMTC $0.71
  • GSIW $1.59
  • Analyst Decision
  • NMTC Strong Buy
  • GSIW
  • Analyst Count
  • NMTC 1
  • GSIW 0
  • Target Price
  • NMTC $1.45
  • GSIW N/A
  • AVG Volume (30 Days)
  • NMTC 176.5K
  • GSIW 2.6M
  • Earning Date
  • NMTC 08-13-2025
  • GSIW 01-01-0001
  • Dividend Yield
  • NMTC N/A
  • GSIW N/A
  • EPS Growth
  • NMTC N/A
  • GSIW N/A
  • EPS
  • NMTC N/A
  • GSIW N/A
  • Revenue
  • NMTC $5,758,777.00
  • GSIW $1,313,795.00
  • Revenue This Year
  • NMTC $157.28
  • GSIW N/A
  • Revenue Next Year
  • NMTC $41.79
  • GSIW N/A
  • P/E Ratio
  • NMTC N/A
  • GSIW N/A
  • Revenue Growth
  • NMTC 54.53
  • GSIW N/A
  • 52 Week Low
  • NMTC $0.40
  • GSIW $0.35
  • 52 Week High
  • NMTC $1.39
  • GSIW $12.30
  • Technical
  • Relative Strength Index (RSI)
  • NMTC 65.31
  • GSIW 75.59
  • Support Level
  • NMTC $0.72
  • GSIW $1.48
  • Resistance Level
  • NMTC $0.77
  • GSIW $1.64
  • Average True Range (ATR)
  • NMTC 0.05
  • GSIW 0.13
  • MACD
  • NMTC 0.01
  • GSIW -0.02
  • Stochastic Oscillator
  • NMTC 82.02
  • GSIW 88.89

About NMTC NeuroOne Medical Technologies Corporation

NeuroOne Medical Technologies Corp operates as a medical technology company. It is focused on the development and commercialization of thin-film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, brain stimulation, and ablation solutions for patients suffering from brain-related disorders. The company business is in one operating segment, which is the business of development and commercialization of products related to comprehensive neuromodulation cEEG and sEEG recording, monitoring, ablation, and brain stimulation solutions.

About GSIW Garden Stage Limited

Garden Stage Ltd is a Hong Kong-based financial services provider principally engaged in the provision of placing and underwriting services; securities dealing and brokerage services; and asset management services. Its business is carried out through its wholly owned Operating Subsidiaries: a) I Win Securities, which is licensed to conduct Type 1 (dealing in securities) regulated activities under the SFO in Hong Kong, and b) I Win Asset Management, which is licensed to conduct Type 4 (advising on securities) and Type 9 (asset management) regulated activities under the SFO in Hong Kong.

Share on Social Networks: